KEY POINTS

GLP-1 medications significantly lower mortality rates in colon cancer patients.

Research analyzed over 6,800 patients to establish drug effectiveness for survival.

Higher survival rates observed with GLP-1 drugs among patients with BMI over 35.

While drugs like Wegovy, Ozempic and Mounjaro are hailed for regulating blood sugar and helping people lose weight, new research suggests they may also reduce the risk of early death in colon cancer patients.

The study , from the University of California San Diego, looked at the effect of glucagon-like peptide-1 receptor agonists — often called simply GLP-1 drugs — in an analysis of more than 6,800 colon cancer patients. They found those who were on the GLP-1 medications were less than half as likely to die within five years compar

See Full Page